Sinovac Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, has filed its 2023 annual report on Form 20-F with the U.S. Securities and E

Beijing, China – April 12, 2024 – Sinovac Biotech Ltd. ("SINOVAC" or the "Company") (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced that its Pol

Beijing, China – March 27, 2024 – Sinovac Biotech Ltd. ("SINOVAC" or the "Company") (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced that the Com

Beijing, China – January 11, 2024 – Sinovac Biotech Ltd. ("SINOVAC" or the "Company") (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced that Reass

The company's launch ceremony was led by Sinovac's CEO and Chairman, Mr. Weidong Yin, alongside Bogotá's Mayor, Claudia López. December 18, 2023, Bogotá, Colombia – Sinovac Biotech Ltd. (

On December 12, 2023, Chilean President Gabriel Boric met with a delegation led by Mr. Yin Weidong, Chairman, President, and CEO of SINOVAC, at the Presidential Palace La Moneda in Chile. Both sides h

On December 5, 2023, Mayor of Bogotá Claudia López and Colombian Ambassador to China Sergio Caffaratti, visited Sinovac Biotech Ltd. ("SINOVAC" or the "Company") in Beijing to meet

Ambassador Musa and SINOVAC Chairman Explore Continued Investment and Cooperation On November 8, Dr. Ismail Hak Musa, Turkish Ambassador to China, visited Sinovac Biotech Ltd. ("SINOVAC" or

Turkish President Recep Tayyip Erdoğan Attends the Inauguration Ceremony for KeyVac on October 31November 1, 2023, Beijing, China – Sinovac Biotech Ltd. ("SINOVAC" or the "Company"

October 20, 2023, Beijing, China – Sinovac Biotech Ltd. ("SINOVAC" or the "Company") (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, today shared its acco

Pioneering Antibody Products and WHO Approved Vaccines Will Advance Prevention and Treatment of Infectious Diseases October 19, 2023, Beijing, China – Sinovac Biotech Ltd. ("SINOVAC" or the

The Company engages in dialogue exploring Chinese investment opportunities in Chile and greater global vaccine accessibility in the interest of human health October 17, 2023, Beijing, China – Sinovac

Vaccine is First to Target Both EV71 and CA16 Viruses, Boosting HFMD PreventionSeptember 21, 2023, Beijing, China – Sinovac Biotech Ltd. ("SINOVAC" or the "Company") (NASDAQ: SVA),

Clinical trials will advance treatment of COVID-19 infection. September 11, 2023, Beijing, China – Sinovac Biotech Ltd. (“SINOVAC” or the “Company”) (NASDAQ: SVA), a leading provider of biopharmaceuti

Board of Directors Unanimously Recommends Sinovac Shareholders NOT Tender Shares for purchase pursuant to the Offer to Purchase BEIJING, China, September 5, 2023 /Business Wire/ -- Sinovac Biotech Ltd

BEIJING, China, August 29, 2023 /Business Wire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, confirmed today that it i

BEIJING, China, August 28 2023 /Business Wire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, announced today that the C

BEIJING, China, August 15, 2023 /Business Wire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, announced today its unaud

July 28, 2023, Beijing, China – Sinovac Biotech Ltd. ("SINOVAC" or the "Company") (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, today announced a streng

June 30, 2023, Beijing, China – Sinovac Biotech Ltd. ("SINOVAC" or the "Company") (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, today announced promisin